Mirobio Ltd
Research and experimental development on biotechnology · Garsington, Oxford
ActiveUnited KingdomIncorporated 2018Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£11,211,430
Cash
£455,523
Turnover
£10,700,902
Profit / loss
£705,069
Current assets
£9,770,285
Creditors < 1 year
£2,176,390
Equity
£11,211,430
Average employees
30
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £11,211,430 | £9,801,249 |
| Equity | £11,211,430 | £9,801,249 |
| Share capital | £5,660 | £5,660 |
| Retained earnings | £9,343,612 | £8,638,543 |
| Assets | ||
| Fixed assets | £4,203,075 | £4,453,905 |
| Property, plant & equipment | £4,203,075 | £4,453,905 |
| Current assets | £9,770,285 | £8,747,179 |
| Cash at bank | £455,523 | £3,295,616 |
| Debtors | £9,314,762 | £5,451,563 |
| Liabilities | ||
| Creditors within one year | £2,176,390 | £2,772,125 |
| Net current assets | £7,593,895 | £5,975,054 |
| Assets less current liabilities | £11,796,970 | £10,428,959 |
| Profit & loss | ||
| Turnover | £10,700,902 | £11,679,701 |
| Administrative expenses | £9,874,319 | £11,025,272 |
| Operating profit | £826,582 | £654,429 |
| Interest receivable | £81,574 | £1,023,646 |
| Interest payable | £18,743 | £39,136 |
| Profit before tax | £889,413 | £1,638,939 |
| Tax | £184,344 | £401,372 |
| Profit / loss | £705,069 | £1,237,567 |
| Operating costs | ||
| Depreciation | £658,891 | £428,718 |
| Operating lease charges | £624,785 | £1,132,366 |
| Audit fees | £24,401 | £20,971 |
| Research & development | £3,100,899 | £3,745,876 |
| People & pay | ||
| Average employees | 30 | 32 |
| Staff costs | £4,289,389 | £4,375,417 |
| Wages & salaries | £2,948,880 | £3,025,196 |
| Social security costs | £462,045 | £722,762 |
| Pension costs | £173,352 | £184,172 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Ernst & Young
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Gilead Sciences Ireland UC
- Ultimate parent
- Gilead Sciences, Inc.
- Ultimate controlling party
- Gilead Sciences, Inc.
- Accounts
- Small company · FRS 102
- Approved
- 2026-09-04, signed by Juan Peche Marin – Lazaro
Related parties (1)
- group undertakings · group undertaking · Amounts owed; unsecured, interest free and payable on demand · 103,042
Share classes (1)
- 56,592,495 Ordinary shares of £0.0001 each
Events after the year end (1)
- There have been no significant events since the balance sheet date that would require disclosure in the financial statements of the Company for the year ended 31 December 2025.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 1 satisfied / released
Fixed · created 2019-08-27 · satisfied 2022-08-22
—
Satisfied